Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
30.33
+1.55 (5.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Nutex Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 292 | 247.65 | 219.29 | 331.53 | 274.03 | 97.06 |
| Revenue Growth (YoY) | 26.02% | 12.93% | -33.85% | 20.98% | 182.34% | - |
| Cost of Revenue | 205.78 | 195.28 | 190.74 | 144.59 | 104.56 | 40.17 |
| Gross Profit | 86.22 | 52.37 | 28.55 | 186.94 | 169.47 | 56.89 |
| Selling, General & Admin | 37.43 | 33.23 | 19.81 | 5.46 | 10.4 | 19.7 |
| Operating Expenses | 58.64 | 53.66 | 33.13 | 13.12 | 16.29 | 22.18 |
| Operating Income | 27.58 | -1.29 | -4.58 | 173.82 | 153.17 | 34.71 |
| Interest Expense | -19.12 | -16.32 | -12.49 | -6.2 | -6.43 | -3.53 |
| Other Non Operating Income (Expenses) | -0.69 | -0.4 | -0.56 | -0.12 | -1 | 0.91 |
| EBT Excluding Unusual Items | 7.78 | -18.01 | -17.63 | 167.5 | 145.74 | 32.09 |
| Merger & Restructuring Charges | -29.08 | -29.34 | -3.89 | -3.55 | - | - |
| Impairment of Goodwill | -4.34 | -1.14 | -398.14 | - | - | - |
| Other Unusual Items | - | - | - | 5.55 | - | - |
| Pretax Income | -29.54 | -48.49 | -419.65 | 169.49 | 145.74 | 32.09 |
| Income Tax Expense | 2.87 | -5.07 | 13.09 | 0.97 | 0.18 | - |
| Earnings From Continuing Operations | -32.41 | -43.42 | -432.74 | 168.53 | 145.56 | 32.09 |
| Minority Interest in Earnings | -8.73 | -2.36 | 7.96 | -35.93 | -39.59 | -11.17 |
| Net Income | -41.13 | -45.79 | -424.78 | 132.59 | 105.97 | 20.92 |
| Net Income to Common | -41.13 | -45.79 | -424.78 | 132.59 | 105.97 | 20.92 |
| Net Income Growth | - | - | - | 25.12% | 406.47% | - |
| Shares Outstanding (Basic) | 5 | 4 | 4 | 4 | 4 | - |
| Shares Outstanding (Diluted) | 5 | 4 | 4 | 4 | 4 | - |
| Shares Change (YoY) | 10.96% | 4.15% | 7.10% | - | - | - |
| EPS (Basic) | -8.48 | -10.39 | -100.36 | 33.55 | 26.81 | - |
| EPS (Diluted) | -8.58 | -10.50 | -100.50 | 33.00 | 26.81 | - |
| EPS Growth | - | - | - | 23.07% | - | - |
| Free Cash Flow | 20.24 | -8.24 | 35.97 | 136.51 | 25.48 | -20.15 |
| Free Cash Flow Per Share | 4.17 | -1.87 | 8.50 | 34.54 | 6.45 | - |
| Gross Margin | 29.53% | 21.15% | 13.02% | 56.39% | 61.84% | 58.62% |
| Operating Margin | 9.45% | -0.52% | -2.09% | 52.43% | 55.90% | 35.76% |
| Profit Margin | -14.09% | -18.49% | -193.70% | 39.99% | 38.67% | 21.56% |
| Free Cash Flow Margin | 6.93% | -3.33% | 16.40% | 41.17% | 9.30% | -20.76% |
| EBITDA | 36.2 | 6.25 | 1.43 | 179.09 | 156.66 | 37.19 |
| EBITDA Margin | 12.40% | 2.52% | 0.65% | 54.02% | 57.17% | 38.32% |
| D&A For EBITDA | 8.62 | 7.54 | 6.01 | 5.27 | 3.48 | 2.48 |
| EBIT | 27.58 | -1.29 | -4.58 | 173.82 | 153.17 | 34.71 |
| EBIT Margin | 9.45% | -0.52% | -2.09% | 52.43% | 55.90% | 35.76% |
| Effective Tax Rate | - | - | - | 0.57% | 0.12% | - |
| Revenue as Reported | 292 | 247.65 | 219.29 | 331.53 | 274.03 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.